… In summary, after adjusting for factors known to significantly impact survival, higher ER/PR
expression status was associated with better DFS in patients with type I endometrial cancer, …

… with reproductive and hormonal factors such as estrogen, progesterone, and androgens.
The … for estrogen and progesterone is associated with the survival of ovarian cancer patients. …

… In conclusion, based on a large-scale and homogenous population, we found ER/PR loss
strongly and independently predicted poor survival for patients with grade I–II EEA, in both …

… Non-Latina black breast cancer patients experience a shorter survival from breast cancer …
-specific survival for the subset of black and white patients with estrogen and/or progesterone …

… survival compared to patients with ER+/PR+ (estrogen receptor positive and progesterone
… Controversy exists regarding the efficacy of hormone blocking therapy for patients with ER+/…

… also can be associated with poorer survival [8]. This decrease in survival could perhaps be a
result of … the effects of HR expression discordance throughout therapy on patient survival [6]. …

… did not impact survival outcomes in the Low-ER group of our study 18,25,26,27 . Survival
analysis by endocrine therapy use in our study was limited by small numbers of patients, and …

… However, it is not known whether tissue sampling of metastatic sites has any significant
effect on patient survival or quality of life [13, 14] and whether the biology of the primary or the …

… Survival and our ability to predict survival for BCBM patients are … of patients who gained
estrogen or progesterone receptors (change from negative to positive) and only 32% of patients …

… We also evaluated survival outcome in patients with anti-HER2 treatment (Figure 1C and
F). HR+/HER2+ patients had better DFS (P = .002) than HR-/HER2+ subtype. There was no …